Mednet Logo
HomePediatric Hematology/OncologyQuestion

Is there any outpatient protocol for cisplatin/doxorubicin neoadjuvant chemotherapy for osteosarcoma?

3 Answers
Mednet Member
Mednet Member
Pediatric Hematology/Oncology · Roswell Park Cancer Institute

Outpatient administration of cisplatin/doxorubicin (albeit at a slightly reduced cisplatin dosage of 100 mg/m²) protocol is documented in the BC Cancer out in Vancouver, British Columbia. We offer this at Roswell, with the addition of mannitol, but it is a long 8-hour day, and close follow-up is rec...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Medical Oncology · University of Texas MD Anderson Cancer Center

The standard doses are 75 mg/m² of dox and 120 mg/m² of CDDP - hard to deliver as an outpatient. Cisplatin is not a schedule-dependent drug, so if there were compelling reasons not allowing hospitalization, one could split the cisplatin into 2 or 3 weekly doses. The old NSCLC regimens used to give w...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Pediatric Hematology/Oncology · Memorial Sloan-Kettering Cancer Center

We also administer cisplatin and doxorubicin as outpatient therapy to our adolescent and young adult (AYA) patients with osteosarcoma. We give the 60 mg/m² dose daily x2 but without the use of mannitol, following a literature search and consensus building to harmonize pediatric and medical oncology ...

Register or Sign In to see full answer